Ron Finklestien
A Rocky Road Ahead: Navigating Enphase Energy’s Stock Amidst a Sharp Decline
Riding the Rollercoaster: Enphase Energy’s Stock Enphase Energy’s stock (NASDAQ: ENPH) has taken a steep downturn, currently trading at $131 per share, representing a ...
Altimmune’s Stock Surge and the Pemvidutide Breakthrough
Altimmune’s Stock Surge and the Pemvidutide Breakthrough
Altimmune, Inc. ALT shares are trading higher Thursday, and the stock has gained more than 140% over the past month. Here’s a look at ...
Japan’s Services PMI Growth in December
Japan Services PMI Expands in December Amid Sharper Growth in New Business
AlxeyPnferov The au Jibun Bank Japan Services PMI rose to 51.5 in December from 50.8 in November, marking the 16th consecutive month of increasing ...
Analysts Predict U.S. Banking Stocks Rally in 2024 Amid Economic Shifts
Analysts Predict U.S. Banking Stocks Rally in 2024 Amid Economic Shifts
A potential soft landing for the U.S. economy has sparked an upswing of interest in U.S. banking stocks, elucidated in a recent note to ...
Is Lamb Weston’s (LW) Stock a Buy After Solid Quarterly Results?
Is Lamb Weston’s (LW) Stock a Buy After Solid Quarterly Results?
After revealing strong fiscal second-quarter results on Thursday, investors might be contemplating whether it’s the opportune moment to grab a slice of Lamb Weston’s ...
Broadcom Transformation: 2024 Outlook
Broadcom: Through the Prism of 2024
The Evolution of Broadcom Following the fortuitous market climate of 2023, 2024 heralds a metamorphosis for Broadcom Inc. (NASDAQ:AVGO). With the long-anticipated acquisition of ...
GigaCloud Surpasses 52-Week Highs: The Tech Surge
GigaCloud Surpasses 52-Week Highs: The Tech Surge
GigaCloud Technology Inc GCT shares rose significantly on Thursday, marking an exceptional period of growth over the past month. Let’s delve into the details ...
Applied Therapeutics Faces Setback with Cardiac Drug in Phase 3 Study
Applied Therapeutics Faces Setback with Cardiac Drug in Phase 3 Study
GreenApple78 Applied Therapeutics (NASDAQ:APLT) has encountered a tempestuous reckoning as its stock plummeted 30% in the after-hours trading on Thursday. The startling nosedive followed ...
Exxon’s Multi-Billion Dollar Writedown on California Assets Amid Earnings Dip
Exxon’s Multi-Billion Dollar Writedown on California Assets Amid Earnings Dip
Spencer Platt/Getty Images News Exxon Mobil (NYSE:XOM) has disclosed that it expects to incur $2.4B-$2.6B in impairments in the fourth quarter related to its ...
Voyager Therapeutics Announces Proposed Public Offering
Voyager Therapeutics Shares Plummet After-Hours Due to $100 Million Public Offering
Voyager Therapeutics Proposes Public Offering Voyager Therapeutics, Inc. VYGR witnessed a significant decline in after-hours trading following the announcement of a proposed public offering ...
